Federal Circuit Again Invalidates Johnson & Johnson's Cordis Corporation Patent Claims Against Medtronic, Inc., Abbott Laboratories, Boston Scientific Corporation

Published: Jun 28, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson subsidiary Cordis Corp. and Pfizer subsidiary Wyeth Pharma. fail to reserve a lower court's rulings invalidating patents for drug-eluting coronary stent technology.A trio of medical device giants notched another win against Johnson & Johnson(NYSE:JNJ) after a Federal Circuit judge upheld a lower court's ruling that invalidated stent patents held by J&J subsidiary Cordis Corp. Device makers Abbott (NYSE:ABT), Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) cemented their previous win the in long-running battle over drug-eluting stent technology and a coating drug called rapamycin.

Help employers find you! Check out all the jobs and post your resume.

Back to news